Lumida
/VERA
⌘K
Vera Therapeutics Inc

Vera Therapeutics Inc

VERA
$35.05USD+4.32%+1.45 today

MARKET CAP

2.5B

P/E (TTM)

FWD P/E

DAY RANGE

$34 – $35

52W RANGE

$23
$56

AI Summary

Stalk
StalkMedium

VERA exhibits a medium-term Stage 2 advancing structure with clear higher highs and higher lows, trading near its rising 9- and 20-day EMAs but below the 50-day and 200-day SMAs. Short-term momentum is neutral as price consolidates around the EMAs without exhaustion, suggesting patience while watching for pullback acceptance into the 9/20 EMA zone. Long-term downtrend remains intact given price below the declining 200-day SMA, posing overhead resistance.

  • FDA accelerated approval of TRUTAKNA enables imminent commercialization.
  • Strong momentum factors underpin recent upward stock trend.
  • Q2 net loss widened to $109.5 M from $76.5 M YoY.
Full analysis →
Insider Trades37 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jul 7, 2026SellVERAMarshall FordycePRESIDENT AND CEO46,250$42.30$2.5B-37.47%+54.27%$2.0M-6.47%10b5-1Sell Now
Jul 7, 2026SellVERAMarshall FordycePRESIDENT AND CEO92,500$22.60$2.5B-37.47%+54.27%$2.1M+0.00%10b5-1Sell Now
Jun 23, 2026SellVERAMarshall FordycePRESIDENT AND CEO18,500$37.93$2.5B-37.47%+54.27%$701.8K-4.46%10b5-1Sell Now
Jun 23, 2026SellVERAMarshall FordycePRESIDENT AND CEO37,000$20.42$2.5B-37.47%+54.27%$755.4K+0.00%10b5-1Sell Now
May 12, 2026SellVERAMarshall FordycePRESIDENT AND CEO18,500$36.74$2.5B-37.47%+54.27%$679.7K-4.05%10b5-1Sell Now
May 12, 2026SellVERAMarshall FordycePRESIDENT AND CEO37,000$19.82$2.5B-37.47%+54.27%$733.3K+0.00%10b5-1Sell Now
Apr 14, 2026SellVERAMarshall FordycePRESIDENT AND CEO22,951$44.05$2.5B-37.47%+54.27%$1.0M-3.11%10b5-1Sell Now
Mar 13, 2026BuyVERAJoseph R YoungSVP, FINANCE, CHIEF ACCT OFFCR10,000$3.94$2.5B-37.47%+54.27%$39.4K+9.58%Sell Now
Feb 23, 2026SellVERALaurence Matthew SkeltonChief Commercial Officer1,582$41.98$2.5B-37.47%+54.27%$66.4K-2.40%Sell Now
Feb 23, 2026SellVERARobert BrennerChief Medical Officer2,151$41.98$2.5B-37.47%+54.27%$90.3K-4.05%Sell Now
Feb 23, 2026SellVERAWilliam D. TurnerChief Regulatory Officer2,187$41.98$2.5B-37.47%+54.27%$91.8K-4.60%Sell Now
Feb 23, 2026SellVERADavid Lee JohnsonChief Operating Officer2,579$41.98$2.5B-37.47%+54.27%$108.3K-5.34%Sell Now
Feb 23, 2026SellVERAJoseph R YoungSVP, FINANCE, CHIEF ACCT OFFCR3,117$41.98$2.5B-37.47%+54.27%$130.9K-4.59%Sell Now
Feb 23, 2026SellVERASean GrantCHIEF FINANCIAL OFFICER4,949$41.98$2.5B-37.47%+54.27%$207.8K-4.15%Sell Now
Feb 23, 2026SellVERAMarshall FordycePRESIDENT AND CEO16,925$41.98$2.5B-37.47%+54.27%$710.6K-6.18%Sell Now
Dec 15, 2025SellVERAWilliam D. TurnerChief Regulatory Officer20,000$32.80$2.5B-37.47%+54.27%$656.1K+0.00%10b5-1Sell Now
Dec 8, 2025SellVERAWilliam D. TurnerChief Regulatory Officer20,000$30.42$2.5B-37.47%+54.27%$608.4K+0.00%10b5-1Sell Now
Dec 3, 2025SellVERAWilliam D. TurnerChief Regulatory Officer20,000$27.77$2.5B-37.47%+54.27%$555.3K+0.00%10b5-1Sell Now
Nov 21, 2025SellVERAJason S CarterChief Legal Officer3,864$27.82$2.5B-37.47%+54.27%$107.5K-7.29%Sell Now
Nov 11, 2025SellVERAJoseph R YoungSVP, FINANCE, CHIEF ACCT OFFCR25,000$19.01$2.5B-37.47%+54.27%$475.3K-3.14%Sell Now
Feb 21, 2025SellVERAMarshall FordycePRESIDENT AND CEO19,688$27.78$2.5B-37.47%+54.27%$546.9K-3.06%10b5-1Sell Now
Jan 8, 2025SellVERAMarshall FordycePRESIDENT AND CEO35,000$22.32$2.5B-37.47%+54.27%$781.2K+0.00%10b5-1Sell Now
Dec 18, 2024BuyVERAMarshall FordycePRESIDENT AND CEO92,661$10.48$2.5B-37.47%+54.27%$971.4K+1.95%10b5-1Sell Now
Dec 11, 2024SellVERAMarshall FordycePRESIDENT AND CEO35,000$24.92$2.5B-37.47%+54.27%$872.2K+0.00%10b5-1Sell Now
Nov 25, 2024SellVERAMarshall FordycePRESIDENT AND CEO38,750$25.44$2.5B-37.47%+54.27%$985.7K+0.00%10b5-1Sell Now
Nov 13, 2024SellVERAMarshall FordycePRESIDENT AND CEO61,250$26.20$2.5B-37.47%+54.27%$1.6M+0.00%10b5-1Sell Now
Oct 23, 2024SellVERAMarshall FordycePRESIDENT AND CEO38,750$21.64$2.5B-37.47%+54.27%$838.7K+0.00%10b5-1Sell Now
Oct 9, 2024SellVERAMarshall FordycePRESIDENT AND CEO31,250$20.57$2.5B-37.47%+54.27%$642.8K+0.00%10b5-1Sell Now
Sep 25, 2024SellVERAMarshall FordycePRESIDENT AND CEO46,250$24.47$2.5B-37.47%+54.27%$1.1M+0.00%10b5-1Sell Now
Sep 11, 2024SellVERAMarshall FordycePRESIDENT AND CEO31,250$20.20$2.5B-37.47%+54.27%$631.2K+0.00%10b5-1Sell Now
Aug 28, 2024SellVERAMarshall FordycePRESIDENT AND CEO45,945$25.30$2.5B-37.47%+54.27%$1.2M-0.53%10b5-1Sell Now
Aug 21, 2024SellVERAMarshall FordycePRESIDENT AND CEO14,471$39.76$2.5B-37.47%+54.27%$575.4K-4.29%10b5-1Sell Now
Aug 14, 2024SellVERAMarshall FordycePRESIDENT AND CEO31,250$20.23$2.5B-37.47%+54.27%$632.2K+0.00%10b5-1Sell Now
May 15, 2024SellVERAJoseph R YoungSVP, FINANCE, CHIEF ACCT OFFCR59,709$25.11$2.5B-37.47%+54.27%$1.5M-0.38%Sell Now
Apr 10, 2024SellVERAJoseph R YoungSVP, FINANCE, CHIEF ACCT OFFCR5,714$40.00$2.5B-37.47%+54.27%$228.6K-9.70%Sell Now
Apr 3, 2024SellVERASean GrantCHIEF FINANCIAL OFFICER218,305$28.28$2.5B-37.47%+54.27%$6.2M-2.98%Sell Now
Dec 29, 2023BuyVERAMarshall FordycePresident and CEO13,516$2.87$2.5B-37.47%+54.27%$38.9K+0.99%Sell Now